| Interleukin 2 with anti-GD2 antibody ch14. 18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial R Ladenstein, U Pötschger, D Valteau-Couanet, R Luksch, V Castel, ... The Lancet Oncology 19 (12), 1617-1629, 2018 | 377 | 2018 |
| Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules MN Gaze, CG Kelly, GR Kerr, A Cull, VJ Cowie, A Gregor, GCW Howard, ... Radiotherapy and oncology 45 (2), 109-116, 1997 | 367 | 1997 |
| Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi … R Ladenstein, U Pötschger, ADJ Pearson, P Brock, R Luksch, V Castel, ... The lancet oncology 18 (4), 500-514, 2017 | 324 | 2017 |
| 177Lu-DOTATATE molecular radiotherapy for childhood neuroblastoma JE Gains, JB Bomanji, NL Fersht, T Sullivan, D D'Souza, KP Sullivan, ... Journal of Nuclear Medicine 52 (7), 1041-1047, 2011 | 185 | 2011 |
| Stell and Maran's head and neck surgery JC Watkinson, MN Gaze, JA Wilson viii, 520p., Index, 2000, 2000 | 182 | 2000 |
| Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial G Bisogno, M Jenney, C Bergeron, SG Melcón, A Ferrari, O Oberlin, ... The Lancet Oncology 19 (8), 1061-1071, 2018 | 181 | 2018 |
| Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma MN Gaze, YC Chang, GD Flux, RJ Mairs, FH Saran, ST Meller Cancer biotherapy & radiopharmaceuticals 20 (2), 195-199, 2005 | 169 | 2005 |
| A systematic review of 131I-meta iodobenzylguanidine molecular radiotherapy for neuroblastoma JS Wilson, JE Gains, V Moroz, K Wheatley, MN Gaze European journal of cancer 50 (4), 801-815, 2014 | 165 | 2014 |
| Superior vena cava obstruction: a modern management strategy PJ Ostler, DP Clarke, AF Watkinson, MN Gaze Clinical oncology 9 (2), 83-89, 1997 | 161 | 1997 |
| Arm morbidity within a trial of mastectomy and either nodal sample with selective radiotherapy or axillary clearance RJ Aitken, MN Gaze, A Rodger, U Chetty, APM Forrest Journal of British Surgery 76 (6), 568-571, 1989 | 154 | 1989 |
| How rapid advances in imaging are defining the future of precision radiation oncology L Beaton, S Bandula, MN Gaze, RA Sharma British journal of cancer 120 (8), 779-790, 2019 | 136 | 2019 |
| Investigation of the role of dinutuximab beta-based immunotherapy in the SIOPEN high-risk neuroblastoma 1 trial (HR-NBL1) R Ladenstein, U Pötschger, D Valteau-Couanet, R Luksch, V Castel, ... Cancers 12 (2), 309, 2020 | 129 | 2020 |
| 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis ND Papathanasiou, MN Gaze, K Sullivan, M Aldridge, W Waddington, ... Journal of Nuclear Medicine 52 (4), 519-525, 2011 | 117 | 2011 |
| Controversies in the management of laryngeal cancer: results of an international survey of patterns of care B O'Sullivan, W Mackillop, R Gilbert, M Gaze, J Lundgren, C Atkinson, ... Radiotherapy and Oncology 31 (1), 23-32, 1994 | 114 | 1994 |
| Neuroendocrine morbidity after pediatric optic gliomas: a longitudinal analysis of 166 children over 30 years HW Gan, K Phipps, K Aquilina, MN Gaze, R Hayward, HA Spoudeas The Journal of Clinical Endocrinology & Metabolism 100 (10), 3787-3799, 2015 | 112 | 2015 |
| Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules SC Erridge, MN Gaze, A Price, CG Kelly, GR Kerr, A Cull, RH MacDougall, ... Clinical Oncology 17 (1), 61-67, 2005 | 108 | 2005 |
| Mucosal immunodeficiency in smokers, and in patients with epithelial head and neck tumours. JR Barton, MA Riad, MN Gaze, AG Maran, A Ferguson Gut 31 (4), 378-382, 1990 | 108 | 1990 |
| Incidence of cavernoma development in children after radiotherapy for brain tumors S Burn, R Gunny, K Phipps, M Gaze, R Hayward Journal of Neurosurgery: Pediatrics 106 (5), 379-383, 2007 | 100 | 2007 |
| Influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma: a report from the HR-NBL1/SIOPEN study K Holmes, U Pötschger, ADJ Pearson, S Sarnacki, G Cecchetto, ... Journal of Clinical Oncology 38 (25), 2902-2915, 2020 | 95 | 2020 |
| Treatment of neuroendocrine tumours in adults with 131I-MIBG therapy JB Bomanji, W Wong, MN Gaze, A Cassoni, W Waddington, J Solano, ... Clinical oncology 15 (4), 193-198, 2003 | 76 | 2003 |